Bessemer Group
RLAY icon

Bessemer Group’s Relay Therapeutics RLAY Stock Holding History

Bessemer Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57M Hold
457,869
– – 0.01% 430
2026
Q1 		$4.56M Hold
457,869
– – 0.01% 512
2025
Q4 		$3.87M Sell
457,869
-126,594
-22% -$903K 0.01% 495
2025
Q3 		$3.05M Sell
584,463
-67
-0% -$255 ﹤0.01% 426
2025
Q2 		$2.02M Hold
584,530
– – ﹤0.01% 476
2025
Q1 		$1.53M Buy
584,530
+67
+0% +$263 ﹤0.01% 552
2024
Q4 		$2.41M Sell
584,463
-170
-0% -$925 ﹤0.01% 610
2024
Q3 		$4.14M Buy
584,633
+170
+0% +$1.27K 0.01% 475
2024
Q2 		$3.81M Hold
584,463
– – 0.01% 410
2024
Q1 		$4.85M Hold
584,463
– – 0.01% 386
2023
Q4 		$6.43M Hold
584,463
– – 0.01% 347
2023
Q3 		$4.92M Hold
584,463
– – 0.01% 361
2023
Q2 		$7.34M Hold
584,463
– – 0.02% 303
2023
Q1 		$9.63M Hold
584,463
– – 0.02% 257
2022
Q4 		$8.73M Hold
584,463
– – 0.02% 267
2022
Q3 		$13.1M Hold
584,463
– – 0.03% 225
2022
Q2 		$9.79M Hold
584,463
– – 0.02% 229
2022
Q1 		$17.5M Hold
584,463
– – 0.04% 197
2021
Q4 		$17.9M Hold
584,463
– – 0.04% 192
2021
Q3 		$18.4M Hold
584,463
– – 0.04% 201
2021
Q2 		$21.4M Hold
584,463
– – 0.05% 203
2021
Q1 		$20.2M Buy
584,463
+53,339
+10% +$2.31M 0.05% 204
2020
Q4 		$22.1M Hold
531,124
– – 0.06% 189
2020
Q3 		$22.6M Buy
+531,124
New +$20.3M 0.07% 180

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Bessemer Group's RLAY Position: Q2 2026 in Review

Bessemer Group held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 457,869 shares worth $8.57M. The position accounts for 0.01% of the portfolio, ranked #430.

Bessemer Group first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. The position peaked at $22.6M in Q3 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Bessemer Group held 457,869 shares of Relay Therapeutics worth $8.57M as of Q2 2026.
  • Bessemer Group left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #430 holding.
  • Bessemer Group first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Bessemer Group's Relay Therapeutics position peaked at $22.6M in Q3 2020.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.